A method has been developed to measure the relative rate of rat tissue kallikrein synthesis which employs a specific antiserum raised against a purified rat urinary kallikrein. Incorporation of [35S]methionine into kallikrein' and protein 20min after intraperitoneal injection was measured in submaxillary gland, pancreas, kidney and descending colon. Kallikrein content was measured with a direct radioimmunoassay, and kallikrein-specific incorporation of [35S]methionine measured after immunoprecipitation. Kallikrein specific radioactivity (c.p.m./mg of enzyme) was about 100-fold greater than that in total protein in both kidney and colon. In contrast, in pancreas the incorporation into the enzyme was only 5-fold higher than into protein, and in submaxillary gland the incorporation was equivalent. Measured as kallikrein-specific radioactivity relative to total protein radioactivity incorporated in 20min, kallikrein represents 0.18% of total protein synthesis in the kidney, 0.34% in the pancreas, 0.41% in the colon, but 7.29% in the submaxillary gland. Dietary Na+' restriction increased the relative rate of kallikrein synthesis 1.8-fold in the kidney without a comparable effect in submaxillary gland. In contrast, testosterone increased the relative rate of synthesis 2.3-fold in submaxillary gland, but decreased it in kidney. The data show that endogenous kallikrein synthesis differs markedly in various tissues, and that interventions which are known to change kallikrein content or excretion also change the relative rate of enzyme synthesis.
Tissue kallikrein (EC 3.4.21.8 ) is a serine proteinase found in renal cortex, salivary glands, exocrine pancreas and gastrointestinal mucosa, and in excretory products and secretions such as sweat, saliva and urine (Schachter, 1980; Nustad et al., 1978; Zeitlin, 1972; Seki et al., 1972) . Its established activity is to liberate kinin peptide from kininogen substrates, although additional enzymic properties have been suggested (Chao et al., 1981; Arakawa & Marita, 1980; ole-Moi Yoi et al., 1979) . Although enzyme activity or quantity is known to be altered at some sites with various dietary manceuvres, drugs or pathological circumstances such as hypertensive or renal parenchymal diseases (Margolius et al., 1974; Margolius & Chao, 1980; Orce et al., 1980; Mitas et al., 1978;  Abbreviations used: PBS, phosphate-buffered saline (0.14M-NaC1/O.Ol M-phosphate, pH7); Chaps, Cuthbert Carretero & Scicli, 1980; Holland et al., 1980) , nothing is known of how these changes are effected. Changes in the rate of enzyme synthesis, activation, secretion or degradation could all possibly be involved.
To investigate the mechanism of these changes, we have begun studies of tissue kallikrein metabolism by measuring its synthesis, simultaneously at several sites, in live animals. Since tissue kallikrein concentrations are known to change in rats either kept on a low-sodium diet (Mimran et al., 1977; Johnston et al., 1975) , or to which testosterone has been chronically administered (Chao et al., 1982) [35S]Methionine (sp. radioactivity -400Ci/mmol; New England Nuclear Corp., Bedford, MA, U.S.A.) was diluted with 0.15M-NaCl to a volume of 0.3-0.5 ml and injected intraperitoneally at a dose between 0.5 and 1.0 pCi/g body wt., depending upon the experiment. The rats were killed after 20min. Preliminary experiments showed that
[35S]methionine incorporation into kallikrein and total protein was linear for at least 45min. Incorporation was detectable by 10min, and labelling in vivo was routinely terminated at 20 min in order to preclude significant secretion of the labelled material (Palade, 1975) .
Sample preparation
After the 20-min labelling period, rats were anaesthetized with ether and tissues removed in the following order: submaxillary glands, pancreas, kidneys and descending colon. Sublingual glands were dissected away, discarded, and the submaxillary glands frozen. Kidney pairs were perfused via the renal arteries with 10-20ml of PBS.
Pancreas and descending colon were rinsed free of debris, and all samples were frozen at -20°C. Subsequent steps were begun within 1 week of the labelling procedure. After thawing, submaxillary and pancreatic tissue were minced and homogenized in 3.Oml of ice-cold PBS with a PotterElvejhem glass homogenizer and Teflon pestle, whereas kidney pairs or colonic tissue were minced and homogenized in 5.0 ml of ice-cold PBS. Sodium deoxycholate was added to each homogenate to a final concentration of 0. 5%. After being left at room temperature for 30 min with occasional mixing, homogenates were spun at 24000g at 4°C for 30min in a Beckman JA-20 rotor. Supernatants were then spun through a column (2.5 cm x 4.5 cm) of Sephadex G-25 (fine grade) previously equilibrated with 0.01M-Tris/HCl, pH8.0, in a centrifugal filter holder (Gelman Instrument Co., Ann Arbor, MI, U.S.A.) to remove salts and excess deoxycholate. Filtrates were stored at -20°C. Kallikrein and total-protein assays
Immunoreactive kallikrein in the prepared homogenates was measured by using the direct radioimmunoassay described by Shimamoto et al. (1979) . The antibody was raised against purified rat urinary kallikrein (Chao, 1978; , which was also used as the radiolabelled competing ligand in the assay. The specificity of the antibody has been reported (Shimamoto et al., 1979) , and it does not crossreact with human or dog urinary kallikrein, collagenase or the serine proteinases plasmin, trypsin, urokinase and rat urinary esterase A. Plasma kallikrein is also unlikely to interfere with the assay, since it has been shown in other laboratories not to cross-react with rat urinary kallikrein antisera (Lawton et al., 1981; Rabito et al., 1982) . Protein concentration of prepared homogenates was determined by the method of Lowry et al. (1951) , with bovine serum albumin as standard.
Determination of [35Slmethionine incorporation into total protein
Duplicate 20 p1 portions of the prepared homogenates were treated with 50ul of 0.1 M-NaOH at 37°C for 30min. Bovine serum albumin and casein hydrolysate (type I, Sigma) were then added to final concentrations of 0.1% and 0.2% respectively. Protein was precipitated with 0.5 ml of 10% (w/v) trichloroacetic acid and the tubes were centrifuged at 4000g for 10min. The pellet was washed twice with 1.0ml of 5% trichloroacetic acid containing 0.2% casein hydrolysate, dissolved in 0.2ml of 0.1 M-NaOH, and transferred to a liquid-scintillation radioactivity-counting cocktail for aqueous samples. The tubes were rinsed with 0.3ml of water, which was added to the cocktail before counting for radioactivity. Polyacrylamide-gel electrophoresis Antiserum precipitates from labelled submaxillary-gland prepared homogenates were examined in slab gels containing 12.5% acrylamide cross-linked with 0.33% NN'-methylenebisacrylamide, with buffers as described by Laemmli (1970) . Immunoprecipitates containing 18pg of kallikrein were dissolved in 0.06ml of a solution containing 0.0625M-Tris/HCl, pH6.8, 2.0% sodium dodecyl sulphate and 4% 2-mercaptoethanol, with a drop of added glycerol before layering the sample on gels. Gels were run at 30mA for 4h and fixed and stained in a solution containing 10% (v/v) acetic acid, 45% (v/v) methanol and 0.1% Coomassie Blue (R-250). After destaining in 10% acetic acid, gels were cut into 3-mm slices. Slices were dissolved in 30% (v/v) H202 (Goodman & Matzura, 1971 ) and counted for radioactivity. Interpretation of data and statistical analysis
The rate of kallikrein synthesis was assessed by calculating the ratio of kallikrein-specific radioactivity of the immunoprecipitate to total incorporated radioactivity of the trichloroacetic acid precipitate per mg of protein. The measure is a relative one, the rate of kallikrein synthesis being compared with that of total protein synthesis within the same animal, and is similar to that used in studies of glucuronidase induction in mice (Swank et al., 1973) . Normalizing the data in this manner eliminated variability of total labelling from animal to animal. However, this variability was not so large that effects on the ratio, due to effects on total protein labelling, could not be determined.
All data are presented as the means+S.E.M. Student's t test for unpaired data was used to assess significance.
Results

Evaluation of antiserum specificity
Antiserum precipitates were generated from [35S]methionine-labelled submaxillary-gland homVol. 218 ogenates and run on sodium dodecyl sulphate/polyacrylamide gels as described in the Experimental section. Fig. 1 shows that essentially all precipitate radioactivity migrated as a single peak slightly behind the purified active urinary kallikrein B run in an adjacent lane. This result, in the tissue most likely to contain proteinases immunologically related to tissue kallikrein, but of various molecular weights (Bothwell et al., 1979; Lazure et al., 1981 ; Shenkein et al., 1979) , suggests that kallikrein, perhaps as kallikrein A , or in precursor or variably glycosylated forms, is precipitated with high specificity. The possibility, however, that proteins of nearly identical electrophoretic mobility in these gels, having similar immunological specificities, might also be precipitated cannot be eliminated.
Tissue-dependent differences in kallikrein content and labelling Table 1 shows that immunoreactive kallikrein content varies widely. Higher concentrations in submaxillary gland and pancreas presumably reflect the existence of kallikrein in storage granules in these tissues (Simson et al., 1979; Bhoola & Dorey, 1971; 0rstavik et al., 1975) . Kallikrein specific radioactivity (kallikrein c.p.m./mg of kallikrein) also varies widely, being significantly higher (P<0.05) in colon or kidney than in submaxillary gland or pancreas (Table 1 ). This finding is of interest, since total protein specific radioactivity (total-protein c.p.m./mg of protein) is almost constant in three of the tissues. Higher total-protein specific radioactivity in pancreas is expected because of the high rate of protein synthesis in that tissue (Hansson, 1959; Kukral et al., 1965) . The ratio of kallikrein specific radioactivity to total protein specific radioactivity, in fact, varies from 1.36 to 89.5 (Table 1) . These higher ratios derived from the higher kallikrein specific radioactivity in kidney and colon, along with low kallikrein content, imply a higher rate of degradation or secretion in these tissues. From the same data, relative rates of kallikrein synthesis in the four tissues can be determined. Measured in this way, kallikrein accounts for from 0.178 to 7.29% of total protein synthesis for the experiment depicted in Table 1 . This measurement of the relative rate of kallikrein synthesis makes it possible to study whether changes in kallikrein levels brought on by the effects of dietary intake, drugs or other interventions, are associated with changes in kallikrein synthesis. Relative rates of kallikrein synthesis with dietary sodium restriction
It is known that both urinary and renal kallikrein levels are increased in rats maintained on a low-sodium diet (Mimran et al., 1977; Johnston et al., 1975) . Fig. 2 confirms this finding and extends it to show that the relative rate of kallikrein synthesis also significantly increased. In contrast, neither kallikrein content nor relative synthesis rate was increased by this diet in the submaxillary glands of the same rats (Fig. 3) .
Relative rates ofkallikrein synthesis with testosterone treatment Testosterone was shown previously to increase submaxillary-gland immunoreactive kallikrein content in castrated male rats (Chao et al., 1982) . Fig. 4 shows that there is a corresponding increase in the relative rate of kallikrein synthesis in this Vof. 218 tissue. However, in the kidney of these same animals, both kallikrein content and relative synthesis rate are significantly decreased by testosterone (Fig. 5) . There was always significant correlation between kallikrein content and relative rate of synthesis in kidney or submaxillary gland with either sodium restriction or testosterone treatment. Linear-regression analysis of the values of Fig. 2, (Webster, 1970) . Here, this general conclusion is reaffirmed with quantitative measurements of immunoreactive kallikrein within the same experiment. Submaxillary-gland kallikrein levels are 70-fold higher than pancreatic, and more than 1000-fold higher than kidney or colon levels. It is interesting to note that the kidney and colon have the highest kallikrein specific radioactivities (kallikrein-specific c.p.m./mg of kallikrein) and the submaxillary gland the lowest. When this kallikrein labelling is expressed relative to total protein labelling, kidney and colon have specific radioactivities that are nearly 90-fold higher than for total protein, whereas submaxillary gland is roughly the same. In the submaxillary gland, therefore, it seems that kallikrein turnover is nearly equivalent to that of total protein, whereas in kidney and colon it is much faster. To determine whether this is the case will now require direct measurements of kallikrein turnover. It should then be possible to consider the relations between turnover rate and functional responsibilities at the different tissue sites, as well as the significance of modulation ofthese rates by various hormones, drugs or diseases. Although it seems probable that these high specific radioactivities are reflections of a high turnover rate, the relative contributions of kallikrein synthesis, secretion or degradation to this rate also remain to be determined.
Low-sodium diets result in increased urinary kallikrein excretion and renal kallikrein content. The present data show that these changes are accompanied by a significant increase in the relative rate of kallikrein synthesis in kidney, but not in submaxillary gland. Submaxillary-gland kallikrein content was also unchanged by the chronic low-sodium diet. This result is interesting in the light of recent work which clearly established that human salivary kallikrein excretion rates are increased by low sodium diet or sodiumretaining steroids (Horwitz et al., 1982) . In their study, only parotid saliva was collected. Immunohistochemical studies have suggested that parotid kallikrein is likely to be detected as an intense apical (luminal) rim of the striated duct cells, quite similar to that seen in the renal tubule (Simson et al., 1979) . On the other hand, submaxillary-gland kallikrein localization by immunohistochemistry has always noted heavy staining associated with cytoplasmic granules (Simson et al., 1979) . We question whether these differences in immunohistochemical enzyme localization, as well as differences in tissue content or relative synthesis rate in response to chronic low-sodium diet, have some implication in differences in functional responsibility of the enzyme in kidney and parotid versus submaxillary gland.
This question is perhaps reinforced by the results of the testosterone studies. There was not only clearly increased relative kallikrein synthesis rate and content in submaxillary gland, but concomitantly reduced content and synthesis in the kidney of castrated male rats. The former findings in submaxillary gland are consistent with previous work suggesting that this enzyme is subject to androgenic stimulation (Chao et al., 1982) . The meaning of the latter finding is unclear, and it is possible that reduced renal kallikrein synthesis only reflects an indirect response of this process to the primary effects of androgen elsewhere.
In any case, it is clear that kallikrein content and synthesis rate are regulated differently in different tissues. Independent control of an enzyme among tissues has been previously reported, as, for example, renin content in the kidney versus the submandibular gland in genetically different strains of the mouse (Tanaka et al., 1980) , or the response to dihydrotestosterone of glucuronidase in the kidney versus various other tissues, also in the mouse (Swank et al., 1973) . It is possible that the tissuespecific responses of kallikrein to the interventions reported here are similar in nature in that, for unknown reasons, the same enzyme is independently regulated among tissues. It is also conceivable that we are measuring different gene products, closely related members of the kallikrein gene family that cannot be distinguished by our antibody (Mason et al., 1983) . In either case, the importance of the question as to whether there are tissue-specific functional responsibilities of this enzyme, or enzyme family, is re-emphasized.
In summary, we have devised a reliable and sensitive method to measure relative rates of kallikrein synthesis in several rat organs simultaneous- 
